Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 351

1.

Iontophoretic transdermal delivery of glycyrrhizin: effects of pH, drug concentration, co-ions, current intensity, and chemical enhancers.

Yamamoto R, Takasuga S, Kominami K, Sutoh C, Kinoshita M, Kanamura K, Takayama K.

Chem Pharm Bull (Tokyo). 2013;61(12):1275-81.

2.

In vitro and in vivo transdermal iontophoretic delivery of naloxone, an opioid antagonist.

Yamamoto R, Takasuga S, Yoshida Y, Mafune S, Kominami K, Sutoh C, Kato Y, Yamauchi M, Ito M, Kanamura K, Kinoshita M.

Int J Pharm. 2012 Jan 17;422(1-2):132-8. doi: 10.1016/j.ijpharm.2011.10.042. Epub 2011 Nov 15.

PMID:
22108639
3.

Iontophoretic transport kinetics of ketorolac in vitro and in vivo: demonstrating local enhanced topical drug delivery to muscle.

Gratieri T, Pujol-Bello E, Gelfuso GM, de Souza JG, Lopez RF, Kalia YN.

Eur J Pharm Biopharm. 2014 Feb;86(2):219-26. doi: 10.1016/j.ejpb.2013.06.009. Epub 2013 Jun 19.

PMID:
23791718
4.

Delivery of a classical antihypertensive agent through the skin by chemical enhancers and iontophoresis.

Nair A, Reddy C, Jacob S.

Skin Res Technol. 2009 May;15(2):187-94. doi: 10.1111/j.1600-0846.2009.00350.x.

PMID:
19622129
5.

Non-invasive iontophoretic delivery of enzymatically active ribonuclease A (13.6 kDa) across intact porcine and human skins.

Dubey S, Kalia YN.

J Control Release. 2010 Aug 3;145(3):203-9. doi: 10.1016/j.jconrel.2010.04.020. Epub 2010 Apr 25.

PMID:
20423719
6.

In-vitro and in-vivo transdermal iontophoretic delivery of tramadol, a centrally acting analgesic.

Takasuga S, Yamamoto R, Mafune S, Sutoh C, Kominami K, Yoshida Y, Ito M, Kinoshita M.

J Pharm Pharmacol. 2011 Nov;63(11):1437-45. doi: 10.1111/j.2042-7158.2011.01355.x. Epub 2011 Sep 27.

PMID:
21988424
7.

Effect of permeation enhancers on the iontophoretic transport of metoprolol tartrate and the drug retention in skin.

Nair A, Vyas H, Shah J, Kumar A.

Drug Deliv. 2011 Jan;18(1):19-25. doi: 10.3109/10717544.2010.509361. Epub 2010 Aug 21.

PMID:
20726811
8.

Transdermal iontophoresis of hydromorphone across hairless rat skin in vitro.

Kumar MG, Lin S.

Pharm Dev Technol. 2009;14(1):106-15. doi: 10.1080/10837450802409479.

PMID:
18825546
9.

A combination of nonionic surfactants and iontophoresis to enhance the transdermal drug delivery of ondansetron HCl and diltiazem HCl.

Silva SM, Hu L, Sousa JJ, Pais AA, Michniak-Kohn BB.

Eur J Pharm Biopharm. 2012 Apr;80(3):663-73. doi: 10.1016/j.ejpb.2011.11.010. Epub 2011 Nov 25.

PMID:
22137964
10.

Transdermal iontophoresis of dexamethasone sodium phosphate in vitro and in vivo: effect of experimental parameters and skin type on drug stability and transport kinetics.

Cázares-Delgadillo J, Balaguer-Fernández C, Calatayud-Pascual A, Ganem-Rondero A, Quintanar-Guerrero D, López-Castellano AC, Merino V, Kalia YN.

Eur J Pharm Biopharm. 2010 Jun;75(2):173-8. doi: 10.1016/j.ejpb.2010.03.011. Epub 2010 Mar 21.

PMID:
20332024
11.

Microneedle assisted iontophoretic transdermal delivery of prochlorperazine edisylate.

Kolli CS, Xiao J, Parsons DL, Babu RJ.

Drug Dev Ind Pharm. 2012 May;38(5):571-6. doi: 10.3109/03639045.2011.617753. Epub 2011 Oct 8.

PMID:
21980925
12.

Enhanced iontophoretic delivery of buspirone hydrochloride across human skin using chemical enhancers.

Meidan VM, Al-Khalili M, Michniak BB.

Int J Pharm. 2003 Oct 2;264(1-2):73-83.

PMID:
12972337
13.

Controlled delivery of ropinirole hydrochloride through skin using modulated iontophoresis and microneedles.

Singh ND, Banga AK.

J Drug Target. 2013 May;21(4):354-66. doi: 10.3109/1061186X.2012.757768. Epub 2013 Jan 11.

PMID:
23311703
14.

Using transdermal iontophoresis to increase granisetron delivery across skin in vitro and in vivo: effect of experimental conditions and a comparison with other enhancement strategies.

Cázares-Delgadillo J, Ganem-Rondero A, Quintanar-Guerrero D, López-Castellano AC, Merino V, Kalia YN.

Eur J Pharm Sci. 2010 Mar 18;39(5):387-93. doi: 10.1016/j.ejps.2010.01.008. Epub 2010 Jan 21.

PMID:
20096354
15.

Transdermal delivery of cytochrome C--A 12.4 kDa protein--across intact skin by constant-current iontophoresis.

Cázares-Delgadillo J, Naik A, Ganem-Rondero A, Quintanar-Guerrero D, Kalia YN.

Pharm Res. 2007 Jul;24(7):1360-8. Epub 2007 Apr 25.

PMID:
17457661
16.

In vitro transdermal iontophoretic delivery of penbutolol sulfate.

Ita KB, Banga AK.

Drug Deliv. 2009 Jan;16(1):11-4. doi: 10.1080/10717540802396976.

PMID:
19555303
17.

Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.

Nolan LM, Corish J, Corrigan OI, Fitzpatrick D.

Int J Pharm. 2007 Aug 16;341(1-2):114-24. Epub 2007 Apr 6.

PMID:
17502130
18.

Screening of venlafaxine hydrochloride for transdermal delivery: passive diffusion and iontophoresis.

Singh G, Ghosh B, Kaushalkumar D, Somsekhar V.

AAPS PharmSciTech. 2008;9(3):791-7. doi: 10.1208/s12249-008-9111-3. Epub 2008 Jul 1.

19.

Controlled iontophoretic delivery of pramipexole: electrotransport kinetics in vitro and in vivo.

Kalaria DR, Patel P, Merino V, Patravale VB, Kalia YN.

Eur J Pharm Biopharm. 2014 Sep;88(1):56-63. doi: 10.1016/j.ejpb.2014.02.002. Epub 2014 Feb 11.

PMID:
24525072
20.

Influence of electronic and formulation variables on transdermal iontophoresis of tacrine hydrochloride.

Patel N, Jain S, Madan P, Lin S.

Pharm Dev Technol. 2015 Jun;20(4):442-57. doi: 10.3109/10837450.2013.879886. Epub 2014 Jan 27.

PMID:
24467234

Supplemental Content

Support Center